SCHEMBL18756126

SCHEMBL18756126

COc1ccc(Cc2cc(C(C)=O)nc(C)c2Cl)cn1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GRM2 Q14416 3/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CYP2C9 P11712 2/20 0.39
▸ ACACB O00763 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ MLLT1 Q03111 1/20 0.36
▸ NNMT P40261 1/20 0.36
▸ MET P08581 1/20 0.36
▸ PABPC1 P11940 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ PTGES O14684 1/20 0.36
▸ NR3C1 P04150 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18756583 0.85 ALDH1A1 (0.46) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL18756165 0.81 ADORA2A (0.45) —
SCHEMBL18756053 0.79 RAB9A (0.38) KMT2A
SCHEMBL18756162 0.78 CHRM1 (0.58) KCNH2
SCHEMBL18756164 0.78 KCNH2 (0.42) GRM2SMN1; SMN2CYP2C9ACACBPIK3CA
SCHEMBL18725359 0.77 KMT2A (0.47) SMN1; SMN2MEN1KMT2AKDM4EMAPT
SCHEMBL21235161 0.76 KCNH2 (0.41) GRM2SMN1; SMN2ACACBPIK3CAKCNH2
SCHEMBL18725367 0.76 CHRM1 (0.51) —
SCHEMBL21235431 0.74 CHRM1 (0.36) GRM2SMN1; SMN2PIK3CAKCNH2
SCHEMBL18756686 0.74 IDH1 (0.40) GRM2SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3156397-B1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2019-08-07 — — EP disclosed
EP-3156397-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2017-04-19 — — EP disclosed
Send feedback